Crossmark

Pentavalent rotavirus vaccine (RotaTeq®) in the prevention of rotavirus gastroenteritis: a profile of its use in the EU

Crossref DOI link: https://doi.org/10.1007/s40267-018-0497-z

Published Online: 2018-03-09

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Syed, Yahiya Y.

Lyseng-Williamson, Katherine A.
License Information

Text and Data Mining valid from 2018-03-09
More Information

Article History

First Online: 9 March 2018

Change Date: 14 March 2018

Change Type: Correction

Change Details: “Monovalent or combination infant vaccines containing one or more of the following: diphtheria-tetanus-acellular pertussis vaccine, Haemophilus influenzae type b vaccine, inactivated poliovirus vaccine or oral poliovirus vaccine, pneumococcal conjugate vaccine and group C meningococcal conjugate vaccine”

Compliance with ethical standards

:

: The preparation of this review was not supported by any external funding.

: Y.Y. Syed and K.A. Lyseng-Williamson are employees of Adis/Springer, are responsible for the article content and declare no conflicts of interest.Additional information about this Adis Drug Review can be found here: ExternalRef removed.